Ocular Eye Allergies and Eye Drop Prescription Medication

Among numerous diseases which are circulating around the world, eye allergies and eye diseases are growing and affecting a large population of people worldwide. Some of these eye allergy diseases cause no harm, while some prove to be fatal. Some of these eye diseases are age-related, while some prominent ones are ocular eye inflammation and eye conjunctivitis. Conjunctivitis is also called ocular allergy, and it occurs when something you are allergic to irritates the conjunctiva, which is a delicate membrane covering the eye. The allergy can cause ocular eye itchiness and burning in both eyes, which can affect a person’s eyesight. Scientists have been successful in developing drugs to control the ocular itching that is associated with conjunctivitis. One drug that can help in tackling this issue is Zerviate.

Eye Drop Prescription

Zerviate is for the treatment of ocular itching associated with ocular allergies. It is available by prescription only, and it is an eye drop used to treat itchy eyes. Clinical experiments prove that it can reduce ocular itching, and it is effective in patients who have moderate to severe cases of conjunctivitis. It is reported that itchy eyes are the most common symptom of eye allergy that drives the patient to seek medical attention. Zerviate is a comfortable drug, and its comfortability was demonstrated in phase 3 trials. The patients self-assessed the drop comfort after instillation using an 11-point pH scale. If the scale is showing alkaline pH (0-3), it means the drug is comfortable, and if it is showing acidic pH (7-10), then the drug is not comfortable. Zerviate instillation showed an average pH>1, which demonstrates its comfortability.

Zerviate Safety Profile and Usage

Zerviate Eye Drop Medication works fast, and it relieves itchy eyes within minutes, and it controls itchy eyes all day, provided two doses are instilled. One drop should be administered in each eye twice daily, and the dosage should be 8 hours apart. It is advised that the eyedropper should not touch the eyelids or surrounding areas as it may lead to contamination. Clinical studies can access the safety profile of Zerviate. Side effects were observed in 1% to 7% of patients which included red eyes, eye pain and blurred vision.  It is reported that 97% of side effects were mild, and no eye pain was reported when this drug was administered to patients ageing 2-17. Another vital fact to demonstrate its safety profile is that less than 1% of patients stopped using Zerviate for treatment due to side effects.